Izumi-Nakaseko Hiroko, Sakamoto Kengo, Goto Ai, Kambayashi Ryuichi, Matsumoto Akio, Takei Yoshinori, Takahara Akira, Sugiyama Atsushi
Department of Pharmacology, Faculty of Medicine, Toho University, Tokyo, Japan.
Ina Research Inc., Nagano, Japan.
Front Pharmacol. 2023 Jan 19;14:1055031. doi: 10.3389/fphar.2023.1055031. eCollection 2023.
We studied time course of pathological remodeling occurring in the cynomolgus monkey hearts against persistent atrioventricular block condition ( = 10). The atrioventricular block induced the ventricular and atrial dilation followed by the ventricular hypertrophy. Interstitial fibrosis in the ventricle was also observed along with gradual increases in the plasma angiotensin II and aldosterone concentrations. These adaptations were associated with the changes in gene expression profiling reflecting fibrosis and hypertrophy. Atrioventricular block reduced the ventricular rate and cardiac output, but the ejection fraction and stroke volume increased, whereas the cardiac output was gradually restored to its basal level. Systolic/diastolic blood pressure after the atrioventricular block was kept equal to or lower than that before the block, according with lack of increase in the plasma catecholamine levels. Chronic atrioventricular block gradually prolonged the QRS width and JT interval, leading to the QT interval prolongation in conscious state. 10 mg/kg of -sotalol hydrochloride induced torsade de pointes (TdP) in 6 out of 10 animals by 15 months. Animals showing longer QTcF under anesthesia after the atrioventricular block developed -sotalol-induced TdP earlier. No marked difference was observed in pharmacokinetics of -sotalol between 1 and 7 months after the atrioventricular block. Each TdP spontaneously terminated, reflecting a monkey's relatively small "effective size of the heart (=∛(left ventricular weight)/wavelength of reentry)". These fundamental knowledge will help better utilize the chronic atrioventricular block monkeys as an proarrhythmia model for detecting drug-induced TdP.
我们研究了食蟹猴心脏在持续性房室传导阻滞状态下(n = 10)发生病理重塑的时间进程。房室传导阻滞导致心室和心房扩张,随后出现心室肥厚。还观察到心室间质纤维化,同时血浆血管紧张素II和醛固酮浓度逐渐升高。这些适应性变化与反映纤维化和肥厚的基因表达谱变化相关。房室传导阻滞降低了心室率和心输出量,但射血分数和每搏量增加,而心输出量逐渐恢复到基础水平。房室传导阻滞后的收缩压/舒张压保持等于或低于阻滞前,这与血浆儿茶酚胺水平未升高一致。慢性房室传导阻滞逐渐延长QRS波宽度和JT间期,导致清醒状态下QT间期延长。10 mg/kg盐酸索他洛尔在15个月时使10只动物中的6只诱发尖端扭转型室性心动过速(TdP)。房室传导阻滞后麻醉状态下QTcF较长的动物更早出现索他洛尔诱发的TdP。房室传导阻滞后1至7个月间,索他洛尔的药代动力学未观察到明显差异。每次TdP均自发终止,这反映了猴子相对较小的“心脏有效大小(=∛(左心室重量)/折返波长)”。这些基础知识将有助于更好地利用慢性房室传导阻滞猴子作为检测药物诱发TdP的促心律失常模型。